6 news items
Cognition Therapeutics Reports Financial Results for the First Quarter 2024 and Provides Business Update
CGTX
7 May 24
existing) grant funding; our ability to grow and manage growth, maintain relationships with suppliers and retain our management and key employees; our
Cognition Therapeutics KOL Event Provided Platform for Valuable Discussion of Current Therapeutic Options and Need for Additional Options to Treat Alzheimer's Disease
CGTX
22 Apr 24
to: competition; our ability to secure new (and retain existing) grant funding; our ability to grow and manage growth, maintain relationships with suppliers
Cognition Therapeutics to Present at the Needham Virtual Healthcare Conference
CGTX
2 Apr 24
to secure new (and retain existing) grant funding; our ability to grow and manage growth, maintain relationships with suppliers and retain our
Cognition Therapeutics Reports Year End 2023 Financial Results and Provides Business Update
CGTX
26 Mar 24
ability to secure new (and retain existing) grant funding; our ability to grow and manage growth, maintain relationships with suppliers and retain our
Cognition Therapeutics to Report Fourth Quarter and Full Year 2023 Results
CGTX
15 Mar 24
(and retain existing) grant funding; our ability to grow and manage growth, maintain relationships with suppliers and retain our management and key
t2eir2jsddog56j md6t1bt48fmt3hpjdg6pqgavi615zhq1w
CGTX
6 Mar 24
, maintain relationships with suppliers and retain our management and key employees; our ability to successfully advance our current and future product
- Prev
- 1
- Next